Related Experiment Video
Updated: Aug 30, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Elevated expression of caveolin-1 at protein and mRNA level in human cirrhotic liver: relation with nitric oxide
Hiroaki Yokomori1, Masaya Oda, Kazunori Yoshimura
1Department of Internal Medicine, Kitasato Institute Medical Center Hospital, 121-1 Arai, Kitamoto 364-8501, Japan.
Background:
Caveolin, the principal structural protein of caveolae, binds with endothelial nitric oxide synthase (eNOS) leading to enzyme inhibition. This study examined the expression of caveolin and eNOS at the protein and mRNA levels in patients with hepatocellular carcinoma and hepatitis C-related cirrhosis, and in control noncirrhotic liver specimens obtained from patients with metastatic liver carcinoma.
Methods:
Anti-eNOS, anti-caveolin-1, and anti-calmodulin antibodies were used for Western blotting. For in situ hybridization (ISH), human eNOS and caveolin-1 peptide nucleic acid probes were used with a catalyzed signal amplification system.
Results:
Western blotting showed marked overexpression of caveolin-1 protein in cirrhotic liver, while caveolin-1 was almost undetectable in control liver tissue. Endothelial NOS was expressed at a slightly higher level in cirrhotic liver than in control liver tissue. Calmodulin was expressed abundantly in control liver tissue and at a low level in cirrhotic liver tissue. By ISH, eNOS mRNA was localized on portal vein and hepatic lining cells, and caveolin-1 mRNA was almost undetectable in normal liver tissue. In cirrhotic liver tissue, caveolin-1 mRNA was overexpressed on hepatic sinusoidal lining cells, while eNOS mRNA expression was similar to that in normal liver.
Conclusions:
Enhanced caveolin-1 expression may be associated with a significant reduction in NO catalytic activity in cirrhosis.
Insights
Enhanced caveolin-1 expression in cirrhotic liver may significantly reduce nitric oxide (NO) activity. This study investigated caveolin and eNOS levels in liver disease patients.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Caveolin binds endothelial nitric oxide synthase (eNOS), inhibiting its activity.
- Caveolae are cellular structures whose principal protein is caveolin.
Purpose of the Study:
- To examine caveolin and eNOS expression at protein and mRNA levels.
- To compare expression in hepatocellular carcinoma and hepatitis C-related cirrhosis patients versus controls.
Main Methods:
- Western blotting using specific antibodies for eNOS, caveolin-1, and calmodulin.
- In situ hybridization (ISH) with peptide nucleic acid probes for eNOS and caveolin-1 mRNA.
Main Results:
- Marked overexpression of caveolin-1 protein and mRNA in cirrhotic liver tissue.
- eNOS protein and mRNA expression showed minimal changes in cirrhosis.
- Calmodulin protein levels were reduced in cirrhotic liver.
Conclusions:
- Increased caveolin-1 expression correlates with reduced NO catalytic activity in cirrhosis.
- Caveolin-1 may play a role in the pathophysiology of liver cirrhosis.
Related Concept Videos
Nitric Oxide Signaling Pathway
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply
